Eledon Pharmaceuticals, Inc. ("Eledon”) (NASDAQ: ELDN) today announced updated results from an investigator-initiated trial con ...

We usually think of these issues as problems of the heart, liver or pancreas. But emerging research points to another crucial ...

Tegoprubart continues to demonstrate a favorable safety and tolerability profile IRVINE, Calif, March 16, 2026 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. ("Eledon") (NASDAQ: ELDN) today ...

C Breakthrough T1D. Learn about the Agostino family, their connection to Type 1 diabetes, and the Breakthrough T1D Nebraska Gala that will take place later this spring.

India, March 17 -- Latest study shows a serious link between emergency room wait times and patient survival. One in ten accident and emergency patients (A&E patients) with visible blood in urine ...

Eledon Pharmaceuticals, Inc. is rated a Strong Buy following positive phase 2 BESTOW results for tegoprubart. Read more on ELDN stock here.

A US study has shown that people with type 1 diabetes are more likely to develop dementia than the general population, highlighting the importance of following up on brain health as we age.

Imagine a patient with Crohn's disease—after months of flares, they are finally in clinical remission. Their biomarkers are stable, their pain has subsided, and their doctors are satisfied. They are ...

TOKYO, March 17 (Reuters) - Shigeaki Mori, the survivor of the Hiroshima atomic bombing whom former U.S. President Barack Obama embraced during a historic visit to the city in 2016, has died at 88, ...

Even though POP can cause symptoms, like feeling a fullness in the vagina, pelvic pain or pressure, or bowel or urinary changes, POP isn’t always bothersome, Dr. Horner says. Just 3% to 6% of women ...

A Lightweight Self-Supervised Representation Learning Framework for Depression Risk Profiling from Synthetic Daily Behavioural Trajectories ...